| Financial Year |
March 31 2023 |
| Monetary Funds |
296,060,000,000.00 |
| Held-for-trading Financial Assets |
2,684,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
82,578,000,000.00 |
| Advances to Suppliers |
30,384,000,000.00 |
| Other Receivables |
36,911,000,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
155,183,000,000.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
48,521,000,000.00 |
| Total Current Assets |
677,288,000,000.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
274,070,000,000.00 |
| Investment Properties |
-- |
| Fixed Assetes |
462,683,000,000.00 |
| Under-construction Projects |
184,649,000,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
812,984,000,000.00 |
| Intangible Assets |
92,242,000,000.00 |
| R&D expenses |
-- |
| Goodwill |
7,246,000,000.00 |
| Long-Term Deferred and Prepaid Expenses |
11,878,000,000.00 |
| Deferred Income Tax Assets |
16,531,000,000.00 |
| Other Non-Current Assets |
39,617,000,000.00 |
| Sub-Total of Non-Current Assets |
2,033,586,000,000.00 |
| Total Assets |
2,710,874,000,000.00 |
| Short-Term Loans |
55,285,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
15,747,000,000.00 |
| Accounts Payable |
256,467,000,000.00 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,289,000,000.00 |
| Taxes Payable |
53,756,000,000.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
68,153,000,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
118,994,000,000.00 |
| Other Current Liabilities |
11,162,000,000.00 |
| Sub-Total of Current Liabilities |
678,078,000,000.00 |
| Long-term Loans |
132,892,000,000.00 |
| Bonds Payable |
26,923,000,000.00 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
143,702,000,000.00 |
| Deferred Income Tax Liabilities |
23,174,000,000.00 |
| Other Non-Current Liabilities |
8,148,000,000.00 |
| Sub-Total of Non-Current Liabilities |
451,802,000,000.00 |
| Total Liabilities |
1,129,880,000,000.00 |
| Paid-In Capital(Or Share Stock) |
183,021,000,000.00 |
| Capital Surplus |
123,613,000,000.00 |
| Surplus Reserve |
224,957,000,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
889,481,000,000.00 |
| Minority Stockholder's Interest |
172,232,000,000.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,408,762,000,000.00 |
| Owner's Equity（Stockholder's Equity） |
1,580,994,000,000.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,710,874,000,000.00 |
